APA

Gassó P., Rodríguez N., Mas S., Pagerols M., Blázquez A., Plana M. T., Torra M., Lázaro L. & Lafuente A. (20151012). Effect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients. : The pharmacogenomics journal.

Chicago

Gassó P, Rodríguez N, Mas S, Pagerols M, Blázquez A, Plana M T, Torra M, Lázaro L and Lafuente A. 20151012. Effect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients. : The pharmacogenomics journal.

Harvard

Gassó P., Rodríguez N., Mas S., Pagerols M., Blázquez A., Plana M. T., Torra M., Lázaro L. and Lafuente A. (20151012). Effect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients. : The pharmacogenomics journal.

MLA

Gassó P, Rodríguez N, Mas S, Pagerols M, Blázquez A, Plana M T, Torra M, Lázaro L and Lafuente A. Effect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients. : The pharmacogenomics journal. 20151012.